Replies to post #74833 on Cytodyn Inc (CYDY)

[Monroe1]

For once he got it right. LMAO

[Borel Fields]

Man, I wish Nature could put Figure 2 on the cover.

Figure 2 shows 6 charts, one per blood chemical, each with a line per patient showing levels at days 0, 3, 7 and (sometimes) 14 days.

The ones I understand are Il-6, the CD8/CD4 ratio and viral load (graphs a, c, and f). Because you are measuring change over time, there is an honest-to-goodness p-value calculable: they are p=.037, p=.001 and p=.011 respectively! On just ten patients!

There are also healthy controls on the some graphs (can someone dig in to identify who?): Il-6 was zero, no surprise but good to show. Viral load was zero by def. The distribution of the CD8/CD4 ratio for controls matched the day 14 leronlimab range and did not show a time trend.

I don't know how to copy the graphs here - go to the pre-print site, find "download PDF," open it and see page 22 of 24.

They are beautiful!

[justdafactss]

Nah, shorting CYDY is just an excuse for the obvious pump and dump that's running out of steam.

Looks more like company dumping than shorting.